NextCure
NXTC · NASDAQ
$5.44+$0.00 (+0.00%)TodayMarket closed ·
Prev close $5.44
EPS: actual vs estimate
Beat the estimate in 4 of the last 8 quarters, by 26.3% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$1.97 | -$2.80 | −42.1% |
| Q1 FY26 | -$2.15 | -$1.87 | +12.8% |
| Q4 FY25 | -$2.46 | -$0.81 | +67.1% |
| Q3 FY25 | -$4.06 | -$3.22 | +20.7% |
| Q2 FY25 | -$4.71 | -$11.29 | −139.8% |
| Q1 FY25 | -$4.90 | -$4.68 | +4.4% |
| Q4 FY24 | -$4.10 | -$4.92 | −20.0% |
| Q3 FY24 | -$4.22 | -$4.92 | −16.5% |
Earnings calls
- Special Call - NextCure, Inc.
- Bank of America 2022 Virtual Biotech SMID Cap Conference
- Bank of America 2022 Healthcare Conference
- Special Call - NextCure, Inc.
- Morgan Stanley 19th Annual Global Healthcare Conference
- BofA Securities 2021 Virtual Health Care Conference
- Special Call - NextCure, Inc.
- Morgan Stanley 18th Annual Global Healthcare Conference
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.